New Tool Predicts Financial Pain for Cancer Patients | Melanoma Dispatch |

"In an online report in the journal Cancer, a team of University of Chicago cancer specialists have described the first tool—11 questions, assembled and refined from conversations with more than 150 patients with advanced cancer—to measure a patient’s risk for, and ability to tolerate, financial stress. The researchers refer to the expense, anxiety, and loss of confidence confronting cancer patients who face large, unpredictable costs, often compounded by decreased ability to work, as “financial toxicity,” and they have named their patient-reported outcome measure COST (COmprehensive Score for financial Toxicity)."